Viewing Study NCT01915134

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2026-02-03 @ 12:23 AM
Study NCT ID: NCT01915134
Status: UNKNOWN
Last Update Posted: 2015-01-01
First Post: 2013-07-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma
Sponsor: Zhejiang Cancer Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Effects of Chemotherapy View
None Stage IVC Nasopharyngeal Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None nasopharyngeal carcinoma View
None Recombinant Human Endostatin View
None chemotherapy View
None gemcitabine and cisplatin View